Tarsus Collection (4 videos)


Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Phase 2a Results for TP-03 to Treat Demodex Blepharitis (Mars)

Channels: Cornea, General, Optometry

Roberto Gonzalez-Salinas, MD, PhD, provides an overview of the phase 2a Mars pilot study findings evaluating the safety and efficacy of an investigational new drug, TP-03 (Tarsus Pharmaceuticals), for the treatment of Demodex blepharitis.

Now available! Review the Phase 2b RCT Jupiter Study results here

Demodex blepharitis • Tarsus • TP-03

Visit Us Online